Sell Aurobindo Pharma For Target Of Rs 600: Sumeet Bagadia
PUBLISHED ON: December 20, 2016 | Duration: 13 min, 45 sec
Sumeet Bagadia, associate director at Choice Broking, says Aurobindo Pharma is looking weak and it has support around Rs 660-665 levels. If these levels are taken away there can be a sharp selloff in the counter wherein it can fall 8-10 per cent to Rs 600, adds Mr Bagadia.
